Literature DB >> 19274724

Evaluation of an antimicrobial silver foam dressing for use with V.A.C. therapy: morphological, mechanical, and antimicrobial properties.

Joanna L Payne1, Archel M Ambrosio.   

Abstract

The V.A.C. Therapy System (KCI, San Antonio, TX) is an integrated wound management system that creates an environment that promotes wound healing. V.A.C. GranuFoam Silver dressing (S-ROCF) is a reticulated, open-celled polyurethane foam having a pore size range of 400-600 microm. The foam is coated with silver to impart antimicrobial properties throughout the dressing. The morphological and key mechanical properties including tensile strength, ultimate elongation, tear strength, and compression resistance of this dressing were compared to the original V.A.C. GranuFoam dressing (ROCF), which is also a reticulated, open-celled polyurethane foam, and were found to be comparable. Furthermore, the antimicrobial property of S-ROCF was evaluated in vitro for efficacy against pathogens commonly found in clinical settings, including Staphylococcus aureus and Pseudomonas aeruginosa. S-ROCF was found to be effective during antimicrobial testing with a 99.99% reduction in colony forming units, and remained effective after 72 h of simulated V.A.C. Therapy. The antimicrobial and mechanical characteristics of the foam were unaffected by aging as demonstrated through an accelerated aging process. The V.A.C. GranuFoam Silver dressing is a specialized antimicrobial dressing for use with the V.A.C. Therapy System that exhibits morphological and mechanical properties comparable to the V.A.C. GranuFoam dressing and provides the added benefit of antimicrobial efficacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274724     DOI: 10.1002/jbm.b.31209

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  6 in total

1.  The increased killing of biofilms in vitro by combining topical silver dressings with topical negative pressure in chronic wounds.

Authors:  Pedro Miguel Ds Valente; Anand Deva; Quan Ngo; Karen Vickery
Journal:  Int Wound J       Date:  2014-04-08       Impact factor: 3.315

2.  Silver toxicity with the use of silver-impregnated dressing and wound vacuum-assisted closure in an immunocompromised patient.

Authors:  Cabrini A Lariviere; Adam B Goldin; Jeffrey Avansino
Journal:  J Am Col Certif Wound Spec       Date:  2011-05-27

3.  ATP7B detoxifies silver in ciliated airway epithelial cells.

Authors:  Aida Ibricevic; Steven L Brody; Wiley J Youngs; Carolyn L Cannon
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-11       Impact factor: 4.219

Review 4.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

Review 5.  Role of negative pressure wound therapy in total hip and knee arthroplasty.

Authors:  Marcelo Bp Siqueira; Deepak Ramanathan; Alison K Klika; Carlos A Higuera; Wael K Barsoum
Journal:  World J Orthop       Date:  2016-01-18

6.  Wound chemotherapy by the use of negative pressure wound therapy and infusion.

Authors:  Nicholas A Giovinco; Trung D Bui; Timothy Fisher; Joseph L Mills; David G Armstrong
Journal:  Eplasty       Date:  2010-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.